Controls

Cystic fibrosis control panel

Maine Molecular Quality ControlsINTROL CF Panel II is designed to monitor the detection of 54 CFTR mutations, genetic risk factors associated with cystic fibrosis. The mutations include the 23 mutations recommended for testing by ACMG and ACOG, and are contained in three bottles in heterozygous format. INTROL controls are manufactured from synthetic DNA suspended in a patented, non-infectious, blood-like matrix. Each control bottle contains two synthetic alleles in mimic of genomic DNA. When used routinely with traditional tools such as Levey-Jennings charts and Westgard Rules, the laboratory is alerted to test system errors so corrective action can be performed before system failures occur.

Maine Molecular Quality Controls

Visit www.rsleads.com/003ml-169


Group B Strep positive control

AcroMetrixA standardized control for the qualitative molecular testing of Group B Streptococcus (GBS), OptiQual GBS Positive Control helps laboratories assess the performance of testing procedures and ensure the quality of results. Laboratories use this control to monitor variation in assay performance over time and among test-kit lots, and to identify increases in random and systematic error. Provided in ready-to-use liquid form, it can either be pipetted directly into the assay system or used with a swab. This product contains whole, intact bacteria and is designed to mimic naturally occurring human specimens containing GBS and is for in vitro diagnostic use.

AcroMetrix

Visit www.rsleads.com/911ml-150


New 5-mL dropper configuration

Bio-Rad LaboratoriesA 5-mL dropper bottle option is available for AmpliTrol III. This product is designed for use by nucleic-acid testing (NAT) labs with qualitative in vitro diagnostic procedures for the detection of HIV-1, HBV, and HCV nucleic acids in human serum or plasma from donations of whole blood and blood components for transfusion. AmpliTrol III is a full-process positive control, used in the same manner as a patient specimen, to monitor sample preparation, amplification, and detection procedures with many commercially available NAT systems. Sizes available include single-use 1 mL and 5 mL with 60-day open-vial stability.

Bio-Rad Laboratories

Visit www.rsleads.com/907ml-157

 

 

 

BioImagene Announces Integration with Market-Leading Anatomic Pathology ... - MarketWatch (press release)

A Case For Pharmacist Independent Prescribers (PIP) In Ghana? - Ghana News

Warnex Reports Fourth Quarter and Year End 2009 Results - MarketWatch (press release)

Enzo Biochem's Clinical Lab Division Enters Exclusive Agreement with Novel ... - MarketWatch (press release)

ACM Global Central Lab and BioClinica Discuss How Central Lab and EDC ... - MarketWatch (press release)

ICON Continues Asia-Pacific Expansion with New Office in Manila, Philippines - MarketWatch (press release)

Connect with CSU Ag in Southeast Colorado - High Plains Journal

IVAX Diagnostics' Diamedix Subsidiary Enters Canada Through Three Year ... - MarketWatch (press release)

Doctors' Administrative Solutions Enables Clinical Neurosciences, BayCare ... - PR Web (press release)

DiagnoCure announces first quarter 2010 results - PR-USA.net (press release)

 

 

Search more than 3,500 tests, equipment, products, and services for the clinical lab market with company cross references